Viewing Study NCT04387695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-01-24 @ 11:16 PM
Study NCT ID: NCT04387695
Status: UNKNOWN
Last Update Posted: 2023-02-16
First Post: 2020-05-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Hepatocellular Carcinoma View
None Portal Vein Thrombosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma,Portal Vein Tumor Thrombus View
None Radiation ,Sorafenib View